Emergent BioSolutions
EBS
#7887
Rank
โ‚น37.76 B
Marketcap
โ‚น731.89
Share price
-0.92%
Change (1 day)
22.14%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น37.76 Billion

As of July 2026 Emergent BioSolutions has a market cap of โ‚น37.76 Billion. This makes Emergent BioSolutions the world's 7887th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น37.76 B-36.57%
2025โ‚น59.53 B54.86%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Emergent BioSolutions was reported to be:

โ‚น38.01 Billion
by Nasdaq info icon info icon
โ‚น38.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.658 T 36,069.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น30.398 T 80,398.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น9.815 T 25,893.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚น0.51 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น23.47 B-37.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น263.51 B 597.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.389 T 8,876.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel